NeuroPace
NeuroPace71
About
What does NeuroPace do?
NeuroPace develops and commercializes the RNS System, an FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity. This system is designed for adults with drug-resistant focal epilepsy, offering significant seizure reduction and improved quality of life through personalized stimulation and data-driven insights for physicians.
What is NeuroPace's revenue?
StartupHub estimates NeuroPace's annual revenue at $81.1M (range $41.9M to $112.5M, 63% confidence), based on comparable companies in the sector.
What is NeuroPace's valuation?
StartupHub estimates NeuroPace's effective valuation at $280.2M (range $196.2M to $364.3M, 28% confidence), based on comparable companies in the sector.
How much funding has NeuroPace raised?
NeuroPace has raised a total of $475M in funding. The most recent round on record is IPO.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, United States.
When was NeuroPace founded?
NeuroPace was founded in 1997.
What industry does NeuroPace operate in?
NeuroPace operates in MedTech, HealthTech, Brain-Computer Interface, Non-Invasive BCI, Neurotech, HCI.
How many employees does NeuroPace have?
NeuroPace has approximately 248 people on record.
No comments yet. Be the first to share your take.